# NETosis-Dependent Generation of Immunodeficient Low-Density Neutrophils Exacerbates Sepsis-Induced Acute Lung Injury

**Authors:** Ran Sun, Jiamin Huang, Hangfei Jin, Xiao Wen, Xi Gao, Bingwei Sun

PMC · DOI: 10.3390/ijms27042042 · 2026-02-22

## TL;DR

This study shows that low-density neutrophils, generated through a process called NETosis during sepsis, worsen lung damage and may be a new target for treatment.

## Contribution

The study identifies a NETosis-dependent pathway for immunodeficient low-density neutrophil generation in sepsis, linking it to acute lung injury.

## Key findings

- LPS stimulation increases low-density neutrophil (LDN) production.
- LDNs show immunodeficient traits like delayed apoptosis and suppressed T-cell proliferation.
- Inhibiting NETosis with GSK484 reduces LDNs and lung injury in sepsis.

## Abstract

The mechanisms underlying the generation of low-density neutrophils (LDNs), along with their phenotypic characteristics and role in organ injury during sepsis, remain poorly understood. This study utilized lipopolysaccharide (LPS) stimulation to mimic the septic microenvironment. LDNs and high-density neutrophils (HDNs) were isolated via density gradient centrifugation. Single-cell RNA sequencing, in vitro functional assays, and a cecal ligation and puncture (CLP) murine sepsis model were employed, alongside techniques including immunohistochemistry and flow cytometry, to investigate LDN heterogeneity and their role in sepsis-associated acute lung injury (ALI). Results demonstrated that LPS stimulation significantly increased the LDN proportion. Single-cell transcriptomics revealed substantial heterogeneity within LDNs, which exhibited a hyperactivated yet immunodeficient phenotype characterized by delayed apoptosis, impaired migration and phagocytosis, and a heightened capacity to suppress T-cell proliferation. In vivo, the NETosis inhibitor GSK484 reduced LDN generation and alleviated sepsis-associated ALI. In conclusion, sepsis induces the generation of immunodeficient LDNs via a NETosis-dependent pathway, which exacerbates lung injury. Targeting this pathway may represent a novel therapeutic strategy for sepsis.

## Linked entities

- **Chemicals:** GSK484 (PubChem CID 86340175)
- **Diseases:** acute lung injury (MONDO:0006502)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** FUT4 (fucosyltransferase 4) [NCBI Gene 2526] {aka CD15, ELFT, FCT3A, FUC-TIV, FUTIV, LeX}, GPI (glucose-6-phosphate isomerase) [NCBI Gene 2821] {aka AMF, CNSHA4, GNPI, NLK, PGI, PHI}, Elane (elastase, neutrophil expressed) [NCBI Gene 50701] {aka Ela2, F430011M15Rik, NE}, SIGLEC10 (sialic acid binding Ig like lectin 10) [NCBI Gene 89790] {aka PRO940, SIGLEC-10, SLG2}, Lyz1 (lysozyme 1) [NCBI Gene 17110] {aka Lyz, Lyzf3, Lzp-s}, Rplp0 (ribosomal protein lateral stalk subunit P0) [NCBI Gene 11837] {aka 36B4, Arbp, L10E}, Rpl10a (ribosomal protein L10A) [NCBI Gene 19896] {aka CsA-19, Nedd6}, PADI4 (peptidyl arginine deiminase 4) [NCBI Gene 23569] {aka PAD, PAD4, PADI5, PDI4, PDI5}, Mapk6 (mitogen-activated protein kinase 6) [NCBI Gene 50772] {aka 2610021I23Rik, D130053K17Rik, Erk3, Mapk4, Mapk63, Prkm4}, Sell (selectin, lymphocyte) [NCBI Gene 20343] {aka CD62L, L-selectin, LAM-1, LECAM-1, LECAM1, Lnhr}, ARG1 (arginase 1) [NCBI Gene 383], CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, Ifng (interferon gamma) [NCBI Gene 15978] {aka IFN-g, If2f, Ifg}, CXCR4 (C-X-C motif chemokine receptor 4) [NCBI Gene 7852] {aka CD184, D2S201E, FB22, HM89, HSY3RR, LCR1}, SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, Defa4 (defensin, alpha, 4) [NCBI Gene 13238] {aka Crp4, Defa28, Defcr4}, CD274 (CD274 molecule) [NCBI Gene 29126] {aka ADMIO5, B7-H, B7H1, PD-L1, PDCD1L1, PDCD1LG1}, Cxcl12 (C-X-C motif chemokine ligand 12) [NCBI Gene 20315] {aka Pbsf, Scyb12, Sdf1, Tlsf, Tpar1}, Cd69 (CD69 antigen) [NCBI Gene 12515] {aka 5830438K24Rik, AIM, VEA}, Ltf (lactotransferrin) [NCBI Gene 17002] {aka Csp82, Lf, MMS10R, Ms10r}, Arg1 (arginase, liver) [NCBI Gene 11846] {aka AI, Arg-1, PGIF}, CXCR2 (C-X-C motif chemokine receptor 2) [NCBI Gene 3579] {aka CD182, CDw128b, CMKAR2, IL8R2, IL8RA, IL8RB}, Cxcr4 (C-X-C motif chemokine receptor 4) [NCBI Gene 12767] {aka CD184, CXC-R4, CXCR-4, Cmkar4, LESTR, PB-CKR}, MPO (myeloperoxidase) [NCBI Gene 4353], LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, Defa3 (defensin, alpha, 3) [NCBI Gene 13237] {aka Defa27, Defcr-3, Defcr3}, Cxcl2 (C-X-C motif chemokine ligand 2) [NCBI Gene 20310] {aka CINC-2a, GROb, Gro2, MIP-2, MIP-2a, Mgsa-b}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Rps4x (ribosomal protein S4, X-linked) [NCBI Gene 20102] {aka Rps4, Rps4-1}, CEACAM8 (CEA cell adhesion molecule 8) [NCBI Gene 1088] {aka CD66b, CD67, CGM6, NCA-95}, Rpl22 (ribosomal protein L22) [NCBI Gene 19934] {aka 2700038K18Rik}, Hc (hemolytic complement) [NCBI Gene 15139] {aka C5, C5a, He, Hfib2}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, CD28 (CD28 molecule) [NCBI Gene 940] {aka IMD123, Tp44}, Mpo (myeloperoxidase) [NCBI Gene 17523] {aka mKIAA4033}, Rps8 (ribosomal protein S8) [NCBI Gene 20116], Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Ccl4 (C-C motif chemokine ligand 4) [NCBI Gene 20303] {aka AT744.1, Act-2, MIP-1B, Mip1b, Scya4}, Cd274 (CD274 antigen) [NCBI Gene 60533] {aka A530045L16Rik, B7h1, Pdcd1l1, Pdcd1lg1, Pdl1}, Bpi (bactericidal permeablility increasing protein) [NCBI Gene 329547] {aka 9230105K17Rik, Bpifd1}, MME (membrane metalloendopeptidase) [NCBI Gene 4311] {aka CALLA, CD10, CMT2T, NEP, SCA43, SFE}, Rpl5 (ribosomal protein L5) [NCBI Gene 100503670] {aka Ska23, Ska<m23Jus>, Skax23, U21RNA}, CD24 (CD24 molecule) [NCBI Gene 100133941] {aka CD24A}, Camp (cathelicidin antimicrobial peptide) [NCBI Gene 12796] {aka CAP18, CLP, Cnlp, Cramp, FALL39, MCLP}, Ly6g (lymphocyte antigen 6 family member G) [NCBI Gene 546644] {aka Gr-1, Gr1, Ly-6G}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, CD63 (CD63 molecule) [NCBI Gene 967] {aka AD1, HOP-26, ME491, MLA1, OMA81H, Pltgp40}
- **Diseases:** immune dysregulation (OMIM:614878), ARDS (MESH:D012128), hematopoietic dysfunction (MESH:D019337), septic (MESH:D001170), bronchial diseases (MESH:D001982), SLE (MESH:D008180), intra-abdominal sepsis (MESH:D000082122), SFTS (MESH:D000085142), Sepsis (MESH:D018805), CLP (MESH:D002429), cervical dislocation (MESH:D002575), inflammatory cytokines (MESH:D000080424), NETs (MESH:C536657), respiratory failure (MESH:D012131), LDNs (MESH:D001851), autoimmune diseases (MESH:D001327), multiple organ dysfunction (MESH:D009102), blood vessel injury (MESH:D009383), organ damage (MESH:D000092124), gastric cancer (MESH:D013274), chronic graft-versus-host disease (MESH:D000092122), chronic obstructive pulmonary disease (MESH:D029424), interstitial lung disease (MESH:D017563), pulmonary fibrosis (MESH:D011658), HDNs (MESH:D013631), Dysfunction (MESH:D006331), tuberculosis (MESH:D014376), infection (MESH:D007239), bronchitis (MESH:D001991), rupture (MESH:D012421), pulmonary (MESH:D008171), immune disorders (MESH:D007154), AH (MESH:D006519), peritoneal metastasis (MESH:D010538), Tumor (MESH:D009369), cardiopulmonary depression (MESH:D006323), vascular injury (MESH:D057772), pulmonary edema (MESH:D011654), ALI (MESH:D055371), cytotoxicity (MESH:D064420), asthma (MESH:D001249), edema (MESH:D004487), alveolar damage (MESH:D055370), injury to (MESH:D014947), chronic infections (MESH:D000088562), inflammation (MESH:D007249), rheumatoid arthritis (MESH:D001172), pain (MESH:D010146), hematological diseases (MESH:D006402), Death (MESH:D003643), respiratory diseases (MESH:D012140), Immunodeficient (MESH:D007153), small cell lung cancer (MESH:D055752)
- **Chemicals:** glutaraldehyde (MESH:D005976), eosin (MESH:D004801), PBS (MESH:D007854), alcohol (MESH:D000438), vitamin C (MESH:D001205), N-acetylcysteine (MESH:D000111), ethanol (MESH:D000431), DAPI (MESH:C007293), AMD3100 (MESH:C088327), polyA (MESH:D011061), ROS (MESH:D017382), ATP (MESH:D000255), chloral hydrate (MESH:D002697), LPS (MESH:D008070), isoflurane (MESH:D007530), DCFH-DA (MESH:C029569), xylene (MESH:D014992), EDTA (MESH:D004492), fMLP (MESH:D009240), carbon (MESH:D002244), Ca2+ (-), platinum (MESH:D010984), PI (MESH:D011419), paraffin (MESH:D010232), trypan blue (MESH:D014343), HE (MESH:D006371), Percoll (MESH:C016039), Ficoll (MESH:D005362), osmium tetroxide (MESH:D009993), Hematoxylin (MESH:D006416)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Klebsiella (genus) [taxon 570], Bacteroides fragilis (species) [taxon 817], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Escherichia coli (E. coli, species) [taxon 562]
- **Mutations:** 3A-C, C with 50
- **Cell lines:** HDN — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_D020)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940204/full.md

---
Source: https://tomesphere.com/paper/PMC12940204